Citi analyst Ashwin Shirvaikar lowered the firm’s price target on Amdocs to $96 from $99 and keeps a Buy rating on the shares. The analyst views the Q4 results as solid. The long-awaited campus is now done and should be a positive for the company, Shirvaikar tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on DOX:
- Amdocs sees Q1 EPS $1.29- EPS $1.35
- Amdocs reports Q4 EPS $1.29, two estimates $1.30
- Telefonica Enters Expansive, Multi-Year Strategic Collaboration with Amdocs to Provide Cloud-Enabled, Enhanced Digital Experience and Automated Operations in Hispanoamerica
- SITA Selects Amdocs to Accelerate Launch and Monetization of New Products for Air Transport Industry
- Amdocs Limited Reports Fourth Quarter & Full Year Fiscal 2022 Results
